ArticleBritish journal of cancer2015

PIK3CA oncogenic mutations represent a major mechanism of resistance to trastuzumab in HER2/neu overexpressing uterine serous carcinomas.

Jonathan D Black et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.